The stocks below are for educational and informational purposes only. These are NOT buy/sell/hold recommendations from DalalReport. We are NOT SEBI registered. Every stock carries market risk. Do your own research and consult a SEBI-registered certified financial advisor before any investment decision. Past performance is not a guarantee of future results. Read our full disclaimer.
Published Thursday May 21, 2026 at 7:30 AM IST. With GIFT Nifty at 23,810 (+145 pts), Nasdaq +1.54% and Nikkei surging 3.52%, the pre-market picture is bullish. These 10 stocks are curated based on technical chart setups, macro alignment, sector momentum and risk-reward profile. Stocks are ranked by priority — the strongest setups are at the top. Not investment advice.
Why Today’s Pre-Market Sets Up Well for These Picks
Thursday’s pre-market is as clean as it gets: GIFT Nifty +145 pts, Nasdaq +1.54%, Nikkei +3.52%, Brent eased to $105.29, India VIX declining to 18.44. The macro headwinds that crushed markets last week — crude at $109, fear spike — are temporarily in retreat. Today’s picks are specifically chosen to align with three dominant themes for this session: IT and tech on the back of Nasdaq’s strength, defensive pharma given continued volatility risk, and beaten-down quality names that benefit directly from crude easing and rupee stabilisation. Stocks with unclear charts, excessive FII selling or binary catalysts today are excluded regardless of long-term merit.
The Complete Table — All 10 Picks at a Glance
| # | Stock | Sector | Entry / CMP | Target | Stop-Loss | Upside | Setup |
|---|---|---|---|---|---|---|---|
| 1 | Mankind Pharma NSE: MANKIND |
Pharma | ~₹2,580–2,600 | ₹2,800 | ₹2,465 | ~8.5% | Bullish MAs |
| 2 | HCL Technologies NSE: HCLTECH |
IT | Above ₹1,695 | ₹1,800+ | ₹1,640 | ~6%+ | Tech momentum |
| 3 | Sun Pharma NSE: SUNPHARMA |
Pharma | CMP Level | Continued strength | Recent swing low | Defensive | Consistent strength |
| 4 | PB Fintech (PolicyBazaar) NSE: PBFINTECH |
Fintech | ₹2,065 area | ₹2,250 | ₹1,948 | ~8.9% | ATH pullback |
| 5 | Dr. Lal PathLabs NSE: LALPATHLAB |
Healthcare | CMP Level | Uptrend target | 20-day EMA | Defensive | EMA support |
| 6 | GAIL (India) NSE: GAIL |
Gas / Energy | ~₹204–208 | ₹225 | ₹204 | ~8.2% | ₹200 support |
| 7 | Hindalco Industries NSE: HINDALCO |
Metals | Above 20-day EMA | ₹710 | ₹635 | ~11.8% | EMA hold |
| 8 | Shipping Corp of India NSE: SCI |
Shipping | ₹344 | ₹370 | ₹325 | ~7.6% | Uptrend intact |
| 9 | Knowledge Marine NSE: KNOWLEDGEM |
Shipping | ₹2,065 | ₹2,250 | ₹1,948 | ~8.9% | ATH pullback |
| 10 | Dabur India NSE: DABUR |
FMCG | Support zone | Trend reversal | Below support | Reversal | Base building |
Entry prices are approximate based on pre-market positioning. Verify live prices on NSE/BSE at open. Not investment advice. Consult a SEBI-registered advisor.
The Priority Rationale — Why This Order
The ranking is deliberate, not alphabetical. Picks 1–3 (Mankind Pharma, HCL Tech, Sun Pharma) are highest conviction for today specifically — they align with the macro tailwinds (Nasdaq tech rally, pharma defensive positioning, rupee weakness benefiting IT exports) and carry the most favourable risk-reward relative to today’s catalysts. Picks 4–5 (PB Fintech, Dr. Lal PathLabs) are strong chart setups that benefit from the gap-up but are slightly more volatile. Picks 6–8 (GAIL, Hindalco, SCI) carry a “watch” tag because they depend on crude direction — if Brent sustains below $105, these rally; if crude reverses above $108, these underperform. Picks 9–10 (Knowledge Marine, Dabur) are the highest risk-reward but also highest uncertainty — suited for traders, not conservative investors.
Stock-by-Stock Breakdown — The Analytical Case
#1 — Mankind Pharma | Target ₹2,800 | Stop-Loss ₹2,465
Why it’s #1 today: Mankind Pharma is displaying strong bullish momentum with rising moving average structures across multiple timeframes. The stock is building a consistent higher-highs pattern. In today’s macro context, pharma plays a double role — it’s a defensive hide when markets are uncertain AND a direct beneficiary of the weak rupee boosting export revenue. With VIX still at 18.44 and geopolitical risk live, defensive-momentum combinations deserve top priority. The ₹2,465 stop-loss is clearly defined with healthy distance, making this a disciplined trade with a 1:1.5+ risk-reward.
#2 — HCL Technologies | Watch Above ₹1,695 | Stop-Loss ₹1,640
Why it’s #2 today: HCL Tech is today’s single purest play on the macro: Nasdaq surged 1.54% overnight, Taiwan tech jumped 3.37% on Nvidia sentiment, and the rupee above 95 directly inflates HCL’s dollar-denominated revenue in INR terms. This is a three-way tailwind — global tech rally, rupee translation gain and sector breadth strength. Watch for ₹1,695 to be crossed and held at the open. A gap above that level with volume confirmation is the cleanest entry signal today.
#3 — Sun Pharma | Defensive Anchor
Why it’s #3 today: Sun Pharma is on this list for a different reason than #1 and #2 — it’s the safety net. If today’s gap-up reverses on Iran news or FII selling, Sun Pharma is the one stock on this list most likely to hold its value or even gain. Specialty pharma is structurally uncorrelated to oil, geopolitics and FII flows. The stock has shown consistent upward strength. For conservative investors who want exposure to today’s rally without taking the binary risk of energy or metal plays, Sun Pharma is the cleanest vehicle.
#4 — PB Fintech (PolicyBazaar) | Target ₹2,250 | Stop-Loss ₹1,948
Why it’s #4 today: PB Fintech recently touched an all-time high near ₹2,285 and pulled back to 20-day EMA near ₹1,948 for a healthy correction. The bounce back above ₹2,065 with strong volume signals renewed buying interest. In a gap-up market session, this quality fintech name with strong underlying business momentum is a candidate to reclaim its ATH. The stop-loss at ₹1,948 (the EMA level it took support at) is technically clean.
#5 — Dr. Lal PathLabs | Healthcare Defensive
Why it’s #5 today: Dr. Lal PathLabs holds above its 20-day EMA and is exhibiting a steady upward price structure. Healthcare diagnostics is uncorrelated to oil, FII flows and tech cycles — making it a clean defensive addition to balance the more volatile IT and metal picks. A market that opens gap-up but faces resistance around 23,850–23,900 will see rotation into defensives — Lal PathLabs is positioned to benefit from that rotation.
#6 — GAIL (India) | Target ₹225 | Stop-Loss ₹204
Why it’s #6 — and why crude matters: GAIL benefits from positive momentum and critical support alignment near ₹200. As a gas distribution company, GAIL is actually a beneficiary of crude easing — lower oil often correlates with lower LNG prices, improving GAIL’s trading margins. However this is a conditional trade: valid only if Brent stays below $108 today. Check crude at 9:00 AM before entering. The ₹204 stop is tight — keep position size disciplined.
#7 — Hindalco Industries | Target ₹710 | Stop-Loss ₹635
Why it’s #7 — conditional on China: Hindalco is demonstrating strong performance while holding above its 20-day EMA. The highest upside target (11.8%) of any pick today. However metals carry China demand risk as a binary variable. Hindalco works as a trade today only if the broader market gap-up is sustained and global risk appetite remains elevated. The stop at ₹635 is wide — appropriate for metals volatility. Not suitable for conservative players.
#8 — Shipping Corporation of India | Target ₹370 | Stop-Loss ₹325
Why it’s #8 — Iran context matters: Shipping Corp is in a strong uptrend with consistent higher highs and higher lows. As the Iran ceasefire extends, shipping routes through the Persian Gulf become safer — a direct positive for SCI. But this is also the stock most exposed to a reversal if war resumes. The clean uptrend structure and the Iran ceasefire-extension tailwind make this conditionally attractive. Tight stop below ₹325 is essential.
#9 — Knowledge Marine & Engineering | Target ₹2,250 | Stop-Loss ₹1,948
Why it’s #9 — high reward, higher risk: Knowledge Marine recently touched an all-time high near ₹2,285 and bounced sharply (+4% in a recent session) from 20-EMA support at ₹1,948. The structure is strong — buyers defending lower levels. The bounce above ₹2,065 is a re-entry signal. However this is a smallcap name with lower liquidity than large-caps — spreads can widen on volatile days. For experienced traders only. Position size accordingly.
#10 — Dabur India | Base Building — Potential Reversal
Why it’s #10 — longer-term setup: Dabur is at the bottom of today’s list because it is a potential trend reversal setup, not a momentum trade. The stock has held its crucial support zone and is building a base — a pattern that typically takes 2–3 sessions to confirm. For today’s session specifically, Dabur may not move as dramatically as #1–#3. But for investors looking at a 5–7 session trade, the risk-reward of a reversal from this base — in a rising FMCG backdrop with rural consumption recovering — is attractive. Watch the support zone for a clean break above as the entry signal.
What Today’s Macro Means for These Picks
This article is purely for educational and informational purposes. Nothing here constitutes a buy/sell/hold recommendation. DalalReport is NOT SEBI registered and does not manage funds or provide personal financial advice. Every stock listed carries market risk. Stop-losses are suggestions based on chart analysis — they do not guarantee limiting losses in fast-moving markets. Intraday targets may not be achieved on the same day. Always do your own research and consult a SEBI-registered certified financial advisor before any investment decision. DalalReport is not responsible for any trading outcome. Read our full disclaimer.
Curated for Thursday May 21, 2026 pre-market. Chart setups based on technical analysis principles. All target and stop-loss levels for informational purposes only. Pre-market macro: GIFT Nifty +145 pts, Nasdaq +1.54%, Brent $105.29. Markets are volatile — levels can change rapidly after open. Not SEBI registered. Not investment advice. See more Top Stories →
Leave a Reply